chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Myalgia & Fever Experienced severe body aches/pain, terrible  chills, fever 100 degree and sore arms. Symptoms lasted 24 hours
Patient developed a 2 inch x 2 inch rash around injection site within 24 hours of vaccination. Patient self-treated with hydrocortisone cream.
diarrhea; loss their appetite; all over his body fatigue/feeling very tired; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), DECREASED APPETITE (loss their appetite) and FATIGUE (all over his body fatigue/feeling very tired) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in September 2020.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced DIARRHOEA (diarrhea), DECREASED APPETITE (loss their appetite) and FATIGUE (all over his body fatigue/feeling very tired). The patient was treated with BISMUTH SUBSALICYLATE (PEPTO-BISMOL) for Diarrhea, at an unspecified dose and frequency. On 12-Jan-2021, DIARRHOEA (diarrhea), DECREASED APPETITE (loss their appetite) and FATIGUE (all over his body fatigue/feeling very tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included: Blood pressure, Blood thinner, & Cholesterol medications.   This case was linked to MOD-2021-006466 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start dates of the events, a causal relationship cannot be excluded.
Rash covering face and upper chest; including headaches; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 08Apr2021 at 14:00 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis, post-concussion syndrome and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 09Apr2021, the patient experienced rash covering face, upper chest including headaches. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash covering face and upper chest including headaches were recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Red rash appeared on face, trunk, and extremities immediately after taking 1st dose of ROTARIX vaccine 1 ml po. Observed for 20 min, rash appeared to fade no s&s anaphylaxis apparent. No treatment given.
Contracted covid in January.   Cough, sore throat, congestion, headache, fatigue Still have not recovered and am not able to return to normal activities. Symptoms return if I do not rest every few days. Unable to exercise as I did before contracting covid.
1st dose 08 Nov 2022, 2nd 23 Dec 2022; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 59-year-old male patient who received Herpes zoster (Shingrix) (batch number FD47S, expiry date 09-FEB-2024) for prophylaxis.   Concomitant products included VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX).   On 23-DEC-2022, the patient received the 2nd dose of Shingrix. On 23-DEC-2022, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short (Verbatim: 1st dose 08 Nov 2022, 2nd 23 Dec 2022). The outcome of the drug dose administration interval too short was unknown.   Additional Information: GSK Receipt Date: 23-MAR-2023 The reporter was the pharmacist who stated that the 2nd dose of Shingrix was administered to a patient a month and a half after the 1st dose, instead of the recommended 2 months.  The reporter consented to follow up via postal. The patient received 2nd dose of Shingrix, earlier than the recommended interval, which led to shortening of vaccinations schedule.
Around 10-11 hours after the injection, I began to feel body aches and soreness around my neck and upper back.  I started getting chilled but was very hot and feverish.  I went to bed around 10:00pm and had extreme body aches, shaking with chills and had a fever.  I took tylenol around 4am, when my temperature was 100.7.  The fever and aches subsided by the time I got up around 7am, but I was tired all day.  Took another tylenol around 1pm and started feeling normal, fine.  No other issues.
Started with chills at 7 pm; fever of 103 at 9 pm; fever was up to 104 at 12:30 am.  Called  the  Clinic advice nurse and was told to take Tylenol and fluids.  Fever at 12 pm on 2/10/21 is now at 98.8.  Feel very tired and lethargic and can not go back to work.  I?m an employee at Costco  in the pharmacy department.
MUSCULAR FATTIGE, JOINT DISCONFORT, COLDS AND ALERGIES OCCURRING MORE FREQUENTLY
"heavy arm"; pain at injection site & right shoulder & right scapula, Swollen lymph node at right axilla, fatigue Narrative:
VACCINE ERROR, ADMINISTERED AFTER AVAILABLE DATE TO USED. NOTIFICATION OF PFIZER BIVALENT TO END RECEIVED 9.12.23 LATER AFTERNOON.
19JAN99 mom reported p/6PM fever 014 advised fever control meds;mom called back 20JSN99 in AM & came in to be seen for large red circle to lt deltoid area, warm to touch, approx 40x50mm in diameter;told temp to 105;
Info has been received from an RN concerning her grandson who was vaccinated with a dose of MMRII. Ten days post/vax, her grandson developed a measles like rash. Unspecified product quality complaint was involved. Additional info has been requested.
Received DTaP, IPV and MMR 4/20/04, per month on 4/21/04. Left arm was very red. By 4/22/04 Left arm bright pink, slight swelling and very warm to touch. Mom giving Motrin. Child's cheeks on face and arms very flushed. Area of redness on left arm approximately 3.5x4 inches. Advised carry child to doctor. Due to symptoms. Doctor reported reaction to DTaP , possible cellulitis. Child also diagnosed with strep throat. Doctor gave Keflex (for strip) and advised Benadryl and Motrin for arm.
was paralyzed from the waist down; muscle weakness in my legs; had 2nd dose of Pfizer Vaccine on 18Jun2021; This is a spontaneous report from a contactable consumer (Patient). An 85-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown), via an unspecified route of administration, administered in left arm on 18Jun2021 at 10:00 AM (at the age of 85-years-old) as dose 2, single for COVID-19 immunization. The patient medical history included high blood pressure and known allergies. The patient did not have covid prior vaccination. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks of vaccination. Patient received other medications (unspecified) in two weeks. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown), via an unspecified route of administration, administered in left arm on 04Jun2021 at 10: 00 AM as dose 1, single for COVID-19 immunization. The gap between the two doses of vaccine was 14 days which was an inappropriate schedule of vaccine. On 18Jun2021 by 5:30 PM (same day of vaccination), patient was paralyzed from the waist down, and was in ICU for 2 days. The patient was given steroids as the treatment. The paralysis went away but left with muscle weakness in my legs. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization, disability, or permanent damage. The patient was not tested for COVID-19 post vaccination. The outcome of event paralyzed was recovered with sequel, and muscle weakness in legs was not recovered.
localized swelling to left leg, larger than softball size, rash urticarial patches on back and trunk - treatment was benadryl and ibuprofen. No Follow-up Needed as long as improving. 10/30/19 This is a 4 year old male that presents with concerns for reaction to vaccination. He was given his varicella, Kinrix and MMR vaccines 2 days ago. Mother noticed the night of his vaccines that he was developing some erythema and warmth around his left thigh where the vaccines had been administered. He had no other trouble breathing. He had no diarrhea or emesis. She gave some Motrin and let him relax overnight. In the morning he had a couple other areas of rash on his chest and back. He states that the area was itchy and kind of sore, so mother called out triage line and at the time he did not have any other symptoms. No fever, no work of breathing or anything like that, so they were recommended to give some more Motrin and to followup today. Today the area is slightly larger than she saw last night. She had outlined it the night before and it is still warm but the patient is not complaining of any soreness at this time. He does state that it is itchy. He is having no other symptoms today and the areas of rash that were on his abdomen and back appear to be improving. O: Temperature is 97.9. General: Patient is awake and alert sitting up on the clinic table in no acute distress. Eyes: PERR bilaterally without conjunctival injection. ENT: Bilateral tympanic membranes are clear of erythema or bulge. Tympanostomy tubes are in place. Nares are patent without rhinorrhea. Throat is clear of erythema or exudate. CV: Heart is regular rate and rhythm without murmurs, rubs or gallops. Respiratory: Lungs are clear to auscultation bilaterally without wheeze or crackle. Abdomen: If obese and soft and nontender with good bowel sounds in all 4 quadrants. Skin: On the left thigh surrounding the area of his previous vaccination there is an area of erythema and warmth. It is a large patch about 5 cm x 6 cm. It has an irregular border. It is slightly outside the line that mother marked last night. There is no tenderness to palpation of the area. It is nonfluctuant. There are no other rashes or lesions noted on his body. A/P: This appears to be a local reaction most likely to the varicella vaccine that was placed in that leg. As he did not have a previous reaction before and has no intention to have that vaccine again as he has gotten his 2, this is unlikely to happen again. I recommended that they do some Benadryl 12.5 mg every 6 hours as needed to see if that helps and this should help this go away. Strict return precautions were given regarding any fluctuance of the area, fevers or other symptoms. We will also report this to the vaccine registry.
Vasovagal/pre-syncopal event. Accompanied by paresthesia/ weakness/ blurred vision/ lightheadedness.;a seizure-like episode followed' patient was transported to ER via EMS.
Administer a expiry vaccine to herself; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer a expiry vaccine to herself) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013H21B, 019F21A and 007D21A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Mar-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Mar-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer a expiry vaccine to herself). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administer a expiry vaccine to herself) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No treatment information was provided.
Frequent nose bleeds; This is a spontaneous report from a contactable consumer. This 33-year-old non-pregnant female consumer (patient) reported for herself. The patient received first dose of bnt162b2 (Solution for injection, Batch/Lot number was not reported) via an right arm of administration on 08Apr2021 (at the age of 33-year-old), at 9:30 AM as dose 1, single for COVID-19 immunisation. The patient relevant medical history included Asthma. The Concomitant medication's included Sertraline 50 mg. The patient has no known allergies. It was reported that, prior to the vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. On 12Apr2021, the patient experienced Frequent nose bleeds. It was reported that, the patient did not receive any treatment. The clinical outcome of the event unknown.  The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Chief Complaint Patient presents with ? Nasal Congestion     x 2 days.  coughing today, sore throat     Patient is a 42 y.o. female; Pt presents with head congestion x 2 days and a dry cough.  She denies any abdominal pain. She does have her COVID 19 vaccine. Denies any headaches.  Has not taken anything OTC for symptoms. Denies fever or chills, nausea, vomiting or diarrhea.     Head congestion       42 year old female presenting today with head congestion x 2 days. Denies fevers/chills. She did receive her COVID 19 vaccine. Patient was tested for COVID 19 and she did test positive. Reviewed home care and quarantine. Patient stable. VS reviewed. Likely viral URI. See HPI and physical exam to review pertinent information regarding visit. Prescription medication recommendations were reviewed in light of the patient's age, past medical history and comorbidities. Plan of care reviewed and agreed. See patient discharge instructions for more details. Follow up with PCP if symptoms do not improve or go to ER if symptoms worsen.
Case number PHEH2015US019698, is an initial spontaneous report from a pharmacist received on 01 Oct 2015. This report refers to a 24-year-old female pregnant patient. Historical conditions were not reported. No concomitant medication was reported. The patient received FLUVIRIN (batch number: 15114601) intramuscularly in Sep 2015 and later found she was pregnant. No adverse event was reported.
This spontaneous report as received from a pharmacist refers to an unspecified number of patients of unknown age and gender. Information about concurrent conditions, concomitant medication and medical history was not provided. On an unknown date, the unspecified number of patients were vaccinated with improperly stored GARDASIL (lot#, route and frequency were not provided). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
Pt devel hyperventilation, nausea, h/a, backpain, numbness of fingers & hands, inc pulse & BP, substernal pain, elevated temp & mottled face 1hr p/receiving vax; tx DPH then transferred to ER;
Information has been received from a registered nurse concerning a 67 year old male who on 11-FEB-2010 was vaccinated with PNEUMOVAX 23 (lot# 665400/1315Y). On 12-FEB-2010 the patient experienced redness and swelling around the injection site where PNEUMOVAX 23 was given. The patient also reported a fever. The patient sought medical attention via office visit. At the time of the report, the patient's redness around the injection site and swelling around the site persisted. Follow-up information has been received from the registered nurse concerning a 67 year old retired male with no pre-existing allergies or conditions, who on 11-FEB-2010 at 7:10 AM was vaccinated intramuscularly into the right deltoid with a first dose of PNEUMOVAX 23 (lot# 665400/1315Y). It was reported that at the patient's deltoid of arm was redness and tenderness. The patient was treated with KEFLEX 500 mg four times a day and cold compresses. The patient's experience was required doctor visit. There was no laboratory test performed. Subsequently, the patient recovered. This is one of several reports received from the same source. Additional information is not expected.
Pt. experienced pain in R. shoulder and arm starting on 8/11/23.  Reports having spots on R. hand with intermittent numbness of R. hand starting on 8/11/23. Injection site red, raised and size of a silver dollar.  With no improvement pt went to ER on 8/14/23.  Monitored and released same day.  Was told may have hit a nerve during administration of vaccine , use ice intermittently x 1 week and see a provider if no improvements.  On 8/16/23, Mother reports pain improving, redness and swelling now size of nickle , still having intermittent numbness of R. hand.  Mother will call back if no improvements or sx's worsen.  RN
Patient fainted post vaccination. Patient was sitting in observation chair when he fainted. Staff immediately attended to patient, and he regained consciousness rapidly.  He was given water/snacks and monitored for an additional 15 minutes and then left and he stated he was feeling fine. Patient was called later for follow-up and said he was still feeling fine/no issues.
During clinic held on 2/27/2023 a 5-year-old child was giving a dose of Moderna 6m-5y bivalent that had a BUD date of 2/4/2023. The mistake was discovered after the clinic. I contacted Moderna who did a lot activity test and determined that the vaccine was still active on 2/27/2023 and that a readministration of the vaccine was not necessary. No adverse affects were reported by the patient or patient guardian.
pt began having muscle aches a/vax;had been very run down & fatigue p/vax;sore throat & swollen glands;chills, temp up to 104;saw MD temp to 105;Keflex;temp between 98/6-102;throat still sore;
Patient fainted around the pharmacy area within 1-2 min after receiving his covid 19 vaccination. He hit his head on the floor and started bleeding. I approached the patient immediately, he was alert and talking and confused as to what happened. we called emergency right away and paramedics arrived within 5 minutes and patient was taken to hospital for further evaluation. Initial BP 129/74.
Red spot on back (size of baseball); Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Red spot on back (size of baseball)) and VACCINATION SITE PAIN (Pain at injection site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included Shingles (received shingles shot and had an allergic reaction) in January 2021. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), MONTELUKAST SODIUM (SINGULAIR) and HCTZ for an unknown indication.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced RASH MACULAR (Red spot on back (size of baseball)) and VACCINATION SITE PAIN (Pain at injection site). At the time of the report, RASH MACULAR (Red spot on back (size of baseball)) and VACCINATION SITE PAIN (Pain at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications also include Deramil. The patient received shingles shot in January 2021 and had an allergic reaction. No treatment information was provided.
Patient returned to the vaccine room complaining of itching of the entire left arm and nausea.  Injection site was left deltoid.  Patient was given Benadryl 25 mg po and told to return if condition worsened.  Patient voiced understanding.
Patient is a 99-year-old man with prostate cancer and sprouting eyes. No signs of dementia; awake, alert, and oriented by 3 (person, place, time). The patient needs a walker and a person assisting so he can move. He visited the pharmacy and came with two family members. After I evaluated the patient, I administered the vaccine. Just after the administration of his first dose of the Covid-19 Vaccine he felt very dizzy and with severe headaches after standing up.   Family members told me the patient occasionally suffers from dizziness when he changes from the sitting position to the standing position.  I sat him again and he keep telling everyone he did not felt fine. He was semi unconscious; his eyes were almost wide shut and his family members besides me told me he felt cold and never had dizziness like this. Just after that, I asked him if he could breathe, and he nodded yes with his head. I was ready for applying CPR or oxygen depending on the scenario.  But I was very worried for him because of his age and decided to call the ambulance. The paramedics came in half an hour, but he started to feel better after a while. The paramedics got his blood pressure and was low and his glucose levels were high. They recommended the patient to go to the hospital, but he refused. He talked with his family members and instead decided to go home.
About 10 minutes after the shot I felt a warm sensation inside my arm running all the way down to my arm and my hand went numb .  I waited a few more minutes then I was released.  Then 1/2 hour later my eyes were very sensitive to light I wore sunglasses. Then five hours after the shot I had chest discomfort on left side of my chest which felt like I was having a heart attack pain subsided then every 2 hours it came and went until the middle of the night. Then next day still having same chest pain. Then I had difficulty swallowing was choking so I called my doctor. I also had trouble breathing. Dr. Advised to go to ER if I needed to. I rested and rested and monitored myself. Blood pressure fluctuated somewhat. Still had chest pain and discomfort 24 hours after the vaccine. I had never had chest pain or discomfort before. It was quite alarming. Not being able to swallow was alarming also. Several years ago I had an allergic reaction to a cleaning problem some of the same symptoms it was very scary no heart or chest pain with that allergic reaction to a cleaning product that had bleach in the product.